Original articleValidation and Repeatability of a Short Questionnaire for Dry Eye Syndrome
Section snippets
Methods
The study was conducted in compliance with the Good Clinical Practice Program, Institutional Review Board regulations, informed consent regulations, the tenets of the Declaration of Helsinki, and Health Insurance Portability and Accountability Act regulations (HIPAA). All subjects enrolled in the study were adults above 18 years of age who were able to give informed consent.
The WHS was a randomized, double masked, placebo-controlled trial conducted among 39,876 female health professionals in
Results
Among the subset of WHS and PHS participants who were mailed the supplementary questionnaire, 408 WHS (91%) and 219 PHS (91%) participants completed the questionnaire. Comparing responses from the original and the supplementary questionnaires, we observed an ICC of 0.75 for reported frequency of symptoms of dryness and 0.65 for irritation. In addition, we observed that participants’ responses to the dryness and irritation questions were highly correlated with a total symptom score calculated by
Discussion
DES is a common ocular surface disorder of diverse etiology. DES represents a significant public health problem and an important area requiring further study. For large-scale patient-oriented research studies, there is need for a tool that is brief, easy, and noninvasive. The goal of the current study was to validate a short questionnaire composed of three questions that could be used as a simple tool to assess dry eye status in large-scale epidemiologic research studies as well as in the
Abha Gulati, MD, is a Senior Scientific Associate at the Schepens Eye Research Institute, Boston, Massachusetts. Dr Gulati principal research interests include the study of signaling pathways involved in tear secretion and their relation to the ocular surface immuno-inflammatory responses in dry eye syndrome.
References (27)
- et al.
Prevalence of dry eye syndrome among US women
Am J Ophthalmol
(2003) - et al.
The epidemiology of dry eye in Melbourne, Australia
Ophthalmology
(1998) - et al.
A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement
Comput Biol Med
(1990) - et al.
Relation between signs and symptoms of dry eye in the elderlyA population-based perspective
Ophthalmology
(1997) The treatment of dry eye
Surv Ophthalmol
(2001)Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes
CLAO J
(1995)- et al.
A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada
Optom Vis Sci
(1997) - et al.
CANDEESThe Canadian Dry Eye Epidemiology Study
Adv Exp Med Biol
(1998) - et al.
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
N Engl J Med
(2005) - et al.
Baseline characteristics of participants in the Women’s Health Study
J Womens Health Gend Based Med
(2000)
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
N Engl J Med
Findings from the aspirin component of the ongoing Physicians’ Health Study
N Engl J Med
Final report on the aspirin component of the ongoing Physicians’ Health Study
N Engl J Med
Cited by (0)
Abha Gulati, MD, is a Senior Scientific Associate at the Schepens Eye Research Institute, Boston, Massachusetts. Dr Gulati principal research interests include the study of signaling pathways involved in tear secretion and their relation to the ocular surface immuno-inflammatory responses in dry eye syndrome.
Debra A. Schaumberg, ScD, OD, MPH, is an Assistant Professor of Medicine and Ophthalmology at Harvard Medical School, Clinical Associate Scientist at the Schepens Eye Research Institute, and the Director of Ophthalmic Epidemiology, Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, Massachusetts. Dr Schaumberg principal research interests regard the roles of both environmental and genetic risk factors, and their interactions, in common eye diseases including dry eye syndrome, cataract, macular degeneration, and diabetic retinopathy.
This study was supported primarily by an unrestricted grant from Pfizer Consumer Healthcare Inc, Morris Plains, New Jersey (R.D., D.A. Schaumberg). Follow-up of the Physicians’ Health Study cohort is supported by grant CA40360 from the National Institutes of Health, and the Women’s Health Study by grants CA47988 and HL43851 from the National Institutes of Health. The study also received funding from the Joint Clinical Research Center, Massachusetts Eye and Ear Infirmary, Schepens Eye Research Institute, Department of Ophthalmology, Boston, Massachusetts.